ICADE (ICAD.PA) Stock Fundamental Analysis

EPA:ICAD • FR0000035081

21.45 EUR
+0.43 (+2.05%)
Last: Feb 27, 2026, 04:18 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ICAD. ICAD was compared to 42 industry peers in the Diversified REITs industry. ICAD has a bad profitability rating. Also its financial health evaluation is rather negative. ICAD is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • ICAD had positive earnings in the past year.
  • In the past year ICAD had a positive cash flow from operations.
  • In multiple years ICAD reported negative net income over the last 5 years.
  • Each year in the past 5 years ICAD had a positive operating cash flow.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • ICAD has a Return On Assets of -1.84%. This is amonst the worse of the industry: ICAD underperforms 80.95% of its industry peers.
  • The Return On Equity of ICAD (-4.78%) is worse than 80.95% of its industry peers.
  • ICAD has a Return On Invested Capital of 2.76%. This is in the lower half of the industry: ICAD underperforms 71.43% of its industry peers.
  • ICAD had an Average Return On Invested Capital over the past 3 years of 2.14%. This is in line with the industry average of 3.46%.
  • The last Return On Invested Capital (2.76%) for ICAD is above the 3 year average (2.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.84%
ROE -4.78%
ROIC 2.76%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • The Operating Margin of ICAD (19.60%) is worse than 78.57% of its industry peers.
  • In the last couple of years the Operating Margin of ICAD has declined.
  • ICAD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 19.6%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • ICAD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ICAD has about the same amout of shares outstanding than it did 1 year ago.
  • ICAD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ICAD is higher compared to a year ago.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • ICAD has an Altman-Z score of 0.64. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
  • ICAD has a Altman-Z score of 0.64. This is in the lower half of the industry: ICAD underperforms 61.90% of its industry peers.
  • ICAD has a debt to FCF ratio of 45.31. This is a negative value and a sign of low solvency as ICAD would need 45.31 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 45.31, ICAD is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.97 indicates that ICAD is somewhat dependend on debt financing.
  • ICAD has a Debt to Equity ratio of 0.97. This is in the lower half of the industry: ICAD underperforms 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.31
Altman-Z 0.64
ROIC/WACC0.95
WACC2.89%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that ICAD should not have too much problems paying its short term obligations.
  • ICAD has a better Current ratio (1.06) than 78.57% of its industry peers.
  • A Quick Ratio of 0.81 indicates that ICAD may have some problems paying its short term obligations.
  • ICAD has a better Quick ratio (0.81) than 76.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.81
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for ICAD have decreased strongly by -72.25% in the last year.
  • The Earnings Per Share has been decreasing by -9.69% on average over the past years.
  • ICAD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.82%.
  • ICAD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.64% yearly.
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%

3.2 Future

  • Based on estimates for the next years, ICAD will show a decrease in Earnings Per Share. The EPS will decrease by -3.39% on average per year.
  • ICAD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.57% yearly.
EPS Next Y10.09%
EPS Next 2Y-1.13%
EPS Next 3Y-3.39%
EPS Next 5YN/A
Revenue Next Year-8.17%
Revenue Next 2Y-5.52%
Revenue Next 3Y-4.57%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • ICAD is valuated cheaply with a Price/Earnings ratio of 7.20.
  • Based on the Price/Earnings ratio, ICAD is valued cheaply inside the industry as 97.62% of the companies are valued more expensively.
  • ICAD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.11.
  • The Price/Forward Earnings ratio is 6.94, which indicates a rather cheap valuation of ICAD.
  • ICAD's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICAD is cheaper than 97.62% of the companies in the same industry.
  • ICAD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.13.
Industry RankSector Rank
PE 7.2
Fwd PE 6.94
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 95.24% of the companies in the same industry are more expensive than ICAD, based on the Enterprise Value to EBITDA ratio.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as ICAD.
Industry RankSector Rank
P/FCF 15.84
EV/EBITDA 10.49
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A cheap valuation may be justified as ICAD's earnings are expected to decrease with -3.39% in the coming years.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y-1.13%
EPS Next 3Y-3.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 9.06%, ICAD is a good candidate for dividend investing.
  • ICAD's Dividend Yield is rather good when compared to the industry average which is at 5.29. ICAD pays more dividend than 90.48% of the companies in the same industry.
  • ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 9.06%

5.2 History

  • The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • The earnings of ICAD are negative and hence is the payout ratio. ICAD will probably not be able to sustain this dividend level.
DP-186.23%
EPS Next 2Y-1.13%
EPS Next 3Y-3.39%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

ICADE

EPA:ICAD (2/27/2026, 4:18:29 PM)

21.45

+0.43 (+2.05%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17
Earnings (Next)04-14
Inst Owners73.16%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.64B
Revenue(TTM)1.50B
Net Income(TTM)-186.70M
Analysts48.7
Price Target22.17 (3.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.06%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-186.23%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.05%
PT rev (3m)-11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.98%
Revenue NY rev (3m)-1.62%
Valuation
Industry RankSector Rank
PE 7.2
Fwd PE 6.94
P/S 1.09
P/FCF 15.84
P/OCF 4.98
P/B 0.42
P/tB 0.42
EV/EBITDA 10.49
EPS(TTM)2.98
EY13.89%
EPS(NY)3.09
Fwd EY14.4%
FCF(TTM)1.35
FCFY6.31%
OCF(TTM)4.3
OCFY20.07%
SpS19.67
BVpS51.19
TBVpS50.76
PEG (NY)0.71
PEG (5Y)N/A
Graham Number58.58
Profitability
Industry RankSector Rank
ROA -1.84%
ROE -4.78%
ROCE 3.87%
ROIC 2.76%
ROICexc 3.38%
ROICexgc 3.4%
OM 19.6%
PM (TTM) N/A
GM N/A
FCFM 6.88%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexgc growth 3Y-8.78%
ROICexgc growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.31
Debt/EBITDA 9.41
Cap/Depr 210.38%
Cap/Sales 15%
Interest Coverage 4.11
Cash Conversion 81.88%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.81
Altman-Z 0.64
F-Score5
WACC2.89%
ROIC/WACC0.95
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
EPS Next Y10.09%
EPS Next 2Y-1.13%
EPS Next 3Y-3.39%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%
Revenue Next Year-8.17%
Revenue Next 2Y-5.52%
Revenue Next 3Y-4.57%
Revenue Next 5YN/A
EBIT growth 1Y74.88%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year51.05%
EBIT Next 3Y13.12%
EBIT Next 5Y8.67%
FCF growth 1Y240.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.65%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%

ICADE / ICAD.PA FAQ

What is the ChartMill fundamental rating of ICADE (ICAD.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICAD.PA.


What is the valuation status of ICADE (ICAD.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to ICADE (ICAD.PA). This can be considered as Undervalued.


How profitable is ICADE (ICAD.PA) stock?

ICADE (ICAD.PA) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for ICAD stock?

The Price/Earnings (PE) ratio for ICADE (ICAD.PA) is 7.2 and the Price/Book (PB) ratio is 0.42.


What is the earnings growth outlook for ICADE?

The Earnings per Share (EPS) of ICADE (ICAD.PA) is expected to grow by 10.09% in the next year.